Search

Search Results
Results 18161 - 18170 of 18997 for stroke
  • Moxicam Capsules
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Moxicam Capsules intended for persons living in Australia.
  • Ezetrol
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Ezetrol intended for persons living in Australia.
  • Symmetrel
    Drug - 9 Dec 2024
    Consumer Medicine Information (CMI) about Symmetrel intended for persons living in Australia.
  • Eprex
    Drug - 2 Dec 2024
    Consumer Medicine Information (CMI) about Eprex intended for persons living in Australia.
  • Risvan
    Drug - 24 Nov 2024
    Consumer Medicine Information (CMI) about Risvan intended for persons living in Australia.
  • Obesity crisis in the U.S. expected to worsen by 2050
    News - 15 Nov 2024
    Over the past three decades, there has been a startling increase in the prevalence of obesity across the USA, at least doubling in adult men and women (aged 25 and older) and older female and male...
  • Triasyn
    Drug - 12 Nov 2024
    Consumer Medicine Information (CMI) about Triasyn intended for persons living in Australia.
  • Dantrium Capsules
    Drug - 11 Nov 2024
    Consumer Medicine Information (CMI) about Dantrium Capsules intended for persons living in Australia.
  • Lupus Research Alliance announces 33 studies to be presented at ACR Convergence 2024
    News - 5 Nov 2024
    The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research...
  • Clexane
    Drug - 23 Oct 2024
    Consumer Medicine Information (CMI) about Clexane intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback